BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31138757)

  • 1. Low concentration of rutin treatment might alleviate the cardiotoxicity effect of pirarubicin on cardiomyocytes via activation of PI3K/AKT/mTOR signaling pathway.
    Fei J; Sun Y; Duan Y; Xia J; Yu S; Ouyang P; Wang T; Zhang G
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qishen Huanwu capsule reduces pirarubicin-induced cardiotoxicity in rats by activating the PI3K/Akt/mTOR pathway.
    Wang F; Wang L; Jiao Y; Wang Z
    Ann Palliat Med; 2020 Sep; 9(5):3453-3461. PubMed ID: 33065796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rutin protects against pirarubicin-induced cardiotoxicity by adjusting microRNA-125b-1-3p-mediated JunD signaling pathway.
    Li Q; Qin M; Li T; Gu Z; Tan Q; Huang P; Ren L
    Mol Cell Biochem; 2020 Mar; 466(1-2):139-148. PubMed ID: 32016695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway.
    Jiao Y; Li Y; Zhang J; Zhang S; Zha Y; Wang J
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tirzepatide protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via PI3K/Akt signaling.
    Chen L; Chen X; Ruan B; Yang H; Yu Y
    Peptides; 2024 Aug; 178():171245. PubMed ID: 38801993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sevoflurane ameliorates doxorubicin-induced myocardial injury by affecting the phosphorylation states of proteins in PI3K/Akt/mTOR signaling pathway.
    Wu Y; Wang J; Yu X; Li D; Han X; Fan L
    Cardiol J; 2017; 24(4):409-418. PubMed ID: 28198521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity.
    Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J
    Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
    Zhang J; Wang M; Ding W; Zhao M; Ye J; Xu Y; Wang Z; Ye D; Li D; Liu J; Wan J
    Biochem Pharmacol; 2020 Oct; 180():114188. PubMed ID: 32750329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamine protects myocardial ischemia-reperfusion injury in rats through the PI3K/Akt signaling pathway.
    Cui ZH; Zhang XJ; Shang HQ; Wang X; Rong D
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):444-451. PubMed ID: 31957859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K/AKT signaling pathway.
    Sun L; Wang H; Xu D; Yu S; Zhang L; Li X
    Bioengineered; 2022 Jan; 13(1):48-60. PubMed ID: 34898356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of cezanne in doxorubicin-induced cardiotoxicity by inhibiting autophagy, apoptosis and oxidative stress.
    Zhang J; Zha Y; Jiao Y; Li Y; Zhang S
    Toxicology; 2023 Feb; 485():153426. PubMed ID: 36639017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rutin attenuates doxorubicin-induced cardiotoxicity via regulating autophagy and apoptosis.
    Ma Y; Yang L; Ma J; Lu L; Wang X; Ren J; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2017 Aug; 1863(8):1904-1911. PubMed ID: 28069395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation endproducts trigger autophagy in cadiomyocyte via RAGE/PI3K/AKT/mTOR pathway.
    Hou X; Hu Z; Xu H; Xu J; Zhang S; Zhong Y; He X; Wang N
    Cardiovasc Diabetol; 2014 Apr; 13():78. PubMed ID: 24725502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent Doxorubicin-induced cardiotoxicity.
    Lv X; Zhu Y; Deng Y; Zhang S; Zhang Q; Zhao B; Li G
    Toxicology; 2020 Aug; 441():152508. PubMed ID: 32525084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BW373U86 upregulates autophagy by inhibiting the PI3K/Akt pathway and regulating the mTOR pathway to protect cardiomyocytes from hypoxia-reoxygenation injury.
    Liang Q; Huang X; Zeng C; Li D; Shi Y; Zhao G; Zhong M
    Can J Physiol Pharmacol; 2020 Oct; 98(10):684-690. PubMed ID: 32955950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on Cardiotoxicity and Mechanism of "Fuzi" Extracts Based on Metabonomics.
    Huang G; Yang L; Zhou W; Tang X; Wang Y; Ma Z; Gao S; Gao Y
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30405071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
    Bai C; Yang X; Zou K; He H; Wang J; Qin H; Yu X; Liu C; Zheng J; Cheng F; Chen J
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):573-84. PubMed ID: 26935715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-496 remedies hypoxia reoxygenation-induced H9c2 cardiomyocyte apoptosis via Hook3-targeted PI3k/Akt/mTOR signaling pathway activation.
    Jin Y; Ni S
    J Cell Biochem; 2020 Jan; 121(1):698-712. PubMed ID: 31436348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MircoRNA-126-5p inhibits apoptosis of endothelial cell in vascular arterial walls via NF-κB/PI3K/AKT/mTOR signaling pathway in atherosclerosis.
    Jia W; Liu J; Tian X; Jiang P; Cheng Z; Meng C
    J Mol Histol; 2022 Feb; 53(1):51-62. PubMed ID: 34981408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAE ameliorates doxorubicin-induced cardiotoxicity via suppressing NHE1 phosphorylation and stimulating PI3K/AKT phosphorylation.
    Yin Y; Niu Q; Hou H; Que H; Mi S; Yang J; Li Z; Wang H; Yu Y; Zhu M; Zhan H; Wang Q; Li P
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109274. PubMed ID: 36252472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.